美股市場個股詳情

BMY 施貴寶

添加自選

44.210
+0.270+0.61%

收盤價 05/01 16:00 (美東)

44.350
+0.140+0.32%

盤後 19:59 (美東)

896.18億總市值-14261市盈率TTM

施貴寶股票討論區

登錄發表評論

Meltyy

04/28 16:18

PDUFA Events for May 2024

The FDA PDUFA Calendar is a chronological calendar of PDUFA target dates as well as Advisory meetings (ADCOMM). PDUFA target dates are dates by which the FDA aims to deliver their decision regarding an NDA or BLA filing. These decisions can however come before the PDUFA target date.
$輝瑞(PFE.US)$$德納維製藥(DVAX.US)$$沙塵暴黃金(SAND.US)$$施貴寶(BMY.US)$$SPDR標普生物科技ETF(XBI.US)$

Gaxsun

04/28 14:43

$施貴寶(BMY.US)$ Sold small lottery tickets yesterday with a plan to buy more $Rio Tinto Ltd(RIO.AU)$ today but instead I bought this turd on a whim. Very upset with myself

Meltyy

04/09 23:48

FDA PDUFA Update…

🗓️ Last week’s PDUFAs:
$Supernus Pharmaceuticals(SUPN.US)$ : CRL 4/8/24 🙁
⇒ SPN-830
⇒ OFF episodes in PD
⇒ NDA
⇒ PDUFA: 4/5/24
$傳奇生物(LEGN.US)$ & $強生(JNJ.US)$ : Approved 🎉
⇒ CARVYKTI (cilta-cel)
⇒ Multiple myeloma
⇒ sBLA
⇒ PDUFA: 4/5/24
$阿斯利康(AZN.US)$ : Approved 🎉
⇒ Enhertu
⇒ HER2+ solid tumors
⇒ sBLA
⇒ PDUFA: Q2 2024
$2seventy bio(TSVT.US)$ & $施貴寶(BMY.US)$ : Approved 🎉
⇒ Abecma
⇒ Multiple myeloma
⇒ sBLA
⇒ Delayed PDUFA
$萬達生物製藥(VNDA.US)$...

Meltyy

04/02 11:27

Major acquisition announced YTD in 2024

A look at one of the major acquisition deals YTD…👇
$MRTX
Acquired By: Bristol-Myers Squibb$施貴寶(BMY.US)$
Date: Jan. 23, 2024
Price: $4.8B
$艾伯維公司(ABBV.US)$$葛蘭素史克(GSK.US)$

frankinglily

04/01 16:50

Updated Complete & Utter M&A Guesses Purely for Entertainment Purposes:

$SPDR標普生物科技ETF(XBI.US)$
$默沙東(MRK.US)$ x $Immunovant(IMVT.US)$
$禮來(LLY.US)$ x $Cytokinetics(CYTK.US)$ (and soon)
$再生元製藥公司(REGN.US)$ x $Apellis Pharmaceuticals(APLS.US)$ (panache & brash)
$吉利德科學(GILD.US)$ x %$Madrigal Pharmaceuticals(MDGL.US)$ (liver king)
$施貴寶(BMY.US)$ x $Iovance Biotherapeutics(IOVA.US)$ (cell Tx boost needed)
$禮來(LLY.US)$ x $Merus(MRUS.US)$ (partner n...

Zerrow

03/28 03:56

$施貴寶(BMY.US)$ 爽啊

已翻譯

Meltyy

03/22 10:48

Mental Health Biotech Catalyst Watchlist

$萬達生物製藥(VNDA.US)$ PDUFA
$Intra-Cellular Therapies(ITCI.US)$ Phase 3
$施貴寶(BMY.US)$ PDUFA
$Alzamend Neuro(ALZN.US)$ Phase 2
$Alzamend Neuro(ALZN.US)$ Phase 2a

Meltyy

03/22 10:47

$Eledon Pharmaceuticals(ELDN.US)$ 10%🟢

First-ever Transplant of Genetically Modified Kidney
⇒ Pig to a Human
⇒ Use of Tegoprubart (anti-CD40L antibody)
⇒ Immunosuppressive treatment
$施貴寶(BMY.US)$